ArriVent BioPharma, Inc. - Common Stock (AVBP)
28.54
-0.55 (-1.89%)
ArriVent BioPharma, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies to address unmet medical needs in various disease areas
The company leverages cutting-edge research and advanced clinical development strategies to create targeted treatments, particularly in oncology and other serious diseases. By prioritizing scientific rigor and collaborative partnerships, ArriVent aims to bring transformative solutions to patients and improve health outcomes globally.
Frequently Asked Questions
Is ArriVent BioPharma, Inc. - Common Stock publicly traded?
Yes, ArriVent BioPharma, Inc. - Common Stock is publicly traded.
What exchange does ArriVent BioPharma, Inc. - Common Stock trade on?
ArriVent BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ArriVent BioPharma, Inc. - Common Stock?
The ticker symbol for ArriVent BioPharma, Inc. - Common Stock is AVBP on the Nasdaq Stock Market
What is the current price of ArriVent BioPharma, Inc. - Common Stock?
The current price of ArriVent BioPharma, Inc. - Common Stock is 28.54
When was ArriVent BioPharma, Inc. - Common Stock last traded?
The last trade of ArriVent BioPharma, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025